NUS
Nu Skin Enterprises, Inc.
Set alert
4.65 USD -0.04 -0.85%
4.63 Day range 4.80
4.53 52-week range 11.54
- YTD
- -51.66%
- 1 year
- -56.21%
- Open
- 4.71
- Prev close
- 4.69
- Mkt cap
- 226.35M
- Vol
- 351.49K
- Avg vol
- 526.88K
- EPS
- -4.51
- P/E
- 0.00
- Div yield
- 3.64%
More statistics
- Low
- 4.63
- High
- 4.80
- Forward P/E
- 6.47
- Beta
- 1.13
- Short ratio
- 1.83
- Inst. own
- 81.02%
- Dividend
- 0.24
- Ex-div date
- Nov 28, 2024
- Earnings
- Feb 12, 2025
- 50-d avg
- 6.96
- 200-d avg
- 9.95
- 1y target
- 6.92
Key statistics
- Market cap
- 334.56M
- Enterprise value
- 614.80M
- Trailing P/E
- 0.00
- Forward P/E
- 6.47
- PEG ratio
- 0.00
- Price / sales
- 0.19
- Price / book
- 0.47
- EPS (TTM)
- -2.09
- Beta
- 1.13
- Dividend yield
- 3.64%
- Payout ratio
- 917.65%
- Profit margin
- -5.81%
- Revenue (TTM)
- 1.78B
- Revenue growth
- -13.80%
- Free cash flow
- 131.05M
- Total cash
- 244.09M
- Total debt
- 530.80M
- Return on equity
- -13.50%
- Shares outstanding
- 49.71M
- Short % of float
- 4.67%
- 50-day average
- 6.96
- 200-day average
- 9.95
Analyst view
Consensus: hold
Hold
Price target (mean) 6.92 +48.7% upside
Now 4.65
- Target (low)
- 6.75
- Target (mean)
- 6.92
- Target (high)
- 7.00
Ratings (0m) 3 0 buy · 3 hold · 0 sell
- Strong buy0
- Buy0
- Hold3
- Sell0
- Strong sell0
Next earnings
Feb 12, 2025
Expected Feb 12, 2025. Consensus EPS estimate 0.24582.
Financials — quick view
NUS Revenue — quarterly 320.11M
NUS Net income — quarterly -249.80M
NUS EPS — quarterly -5.14
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 12, 2025 | Dec 1, 2024 | 0.21 | — | — | — |
| Nov 7, 2024 | Sep 1, 2024 | 0.20 | 0.17 | -0.03 | -15.00% |
| Aug 8, 2024 | Jun 1, 2024 | 0.18 | 0.21 | +0.03 | +16.67% |
| May 8, 2024 | Mar 1, 2024 | 0.05 | 0.09 | +0.04 | +80.00% |
| Feb 14, 2024 | Dec 1, 2023 | 0.29 | 0.37 | +0.08 | +27.59% |
| Nov 1, 2023 | Sep 1, 2023 | 0.64 | 0.56 | -0.08 | -12.50% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 20, 2024 | DA Davidson | main | Neutral | Neutral |
| Oct 22, 2024 | Citigroup | main | Neutral | Neutral |
| Aug 12, 2024 | DA Davidson | main | Neutral | Neutral |
| Aug 9, 2024 | Citigroup | main | Neutral | Neutral |
| May 9, 2024 | DA Davidson | main | Neutral | Neutral |
| Jan 5, 2024 | DA Davidson | main | Neutral | Neutral |
About Nu Skin Enterprises, Inc.
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Country
- United States
- Website
- nuskin.com
News
- Nu Skin Enterprises Sees FY2026 Adj EPS $0.70-$0.90 vs $1.00 Est; Lowers FY2026 Sales Guidance from $1.350B-$1.500B to $1.280B-$1.350B vs $1.425B Est
- Nu Skin Enterprises Sees Q3 Adj EPS $0.10-$0.20 vs $0.32 Est; Sees Sales $310.000M-$340.000M vs $375.500M Est
- Nu Skin Enterprises Q2 Adj. EPS $0.20, Inline, Sales $320.112M Miss $345.200M Estimate
- Nu Skin Enterprises Stockholders Approve Amended And Restated 2024 Omnibus Incentive Plan; Amended Plan Increases Share Authorization By 2.85M Shares; Plan Termination Date Extended To May 28, 2036
- Nu Skin Enterprises Lowers FY2026 GAAP EPS Guidance from $0.80-$1.20 to $0.70-$1.10 vs $1.00 Est; Affirms FY2026 Sales Guidance of $1.350B-$1.500B vs $1.427B Est
- Nu Skin Enterprises Sees Q2 GAAP EPS $0.15-$0.25 vs $0.23 Est; Sees Sales $330.000M-$360.000M vs $361.000M Est
- Nu Skin Enterprises Q1 Adj. EPS $0.14 Misses $0.15 Estimate, Sales $320.600M Miss $329.700M Estimate
- Nu Skin Enterprises Appoints Chelsea Lantz Interim CFO, Effective Immediately, Succeeding James Thomas
- Nu Skin Enterprises Appoints Chayce Clark COO, Effective Immediately
- Pinterest Posts Downbeat Results, Joins DraftKings, Toast, Expedia And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Your note
Sign in to keep a note on NUS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BATTLE EMMA S. | Director | Stock Award(Grant) | Jun 6, 2024 | 19,223 |
| CAMPBELL DANIEL W | Director | Stock Award(Grant) | Jun 6, 2024 | 117,030 |
| CLARK CHAYCE DAVID | General Counsel | Stock Award(Grant) | Feb 26, 2024 | 158,175 |
| LIPMAN ANDREW D | Director | Sale | May 27, 2024 | 23,225 |
| NATHANSON LAURA | Director | Stock Award(Grant) | Jun 6, 2024 | 21,630 |
| SHEN ZHEQING | Director | Stock Award(Grant) | Jun 6, 2024 | 33,195 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 10.27% | 5,104,656 | 34.35M | Sep 29, 2024 |
| Blackrock Inc. | 9.24% | 4,592,141 | 30.91M | Sep 29, 2024 |
| Shaw D.E. & Co., Inc. | 4.06% | 2,020,057 | 13.59M | Sep 29, 2024 |
| Renaissance Technologies, LLC | 3.69% | 1,832,196 | 12.33M | Sep 29, 2024 |
| Millennium Management Llc | 2.61% | 1,296,590 | 8.73M | Sep 29, 2024 |
| State Street Corporation | 2.51% | 1,245,677 | 8.38M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Pacer Small Cap U.S. Cash Cows 100 ETF | 4.77% | 2,373,503 | 15.97M | Jul 30, 2024 |
| Vanguard Total Stock Market Index Fund | 3.28% | 1,631,724 | 10.98M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.69% | 1,335,112 | 8.99M | Oct 30, 2024 |
| Federated Hermes MDT Small Cap Core Fund | 2.35% | 1,166,788 | 7.85M | Jul 30, 2024 |
| Vanguard Extended Market Index Fund | 1.63% | 809,977 | 5.45M | Sep 29, 2024 |
| Schwab Strategic Tr-Schwab Fundamental U.S. Small Company Index ETF | 1.29% | 641,656 | 4.32M | Aug 30, 2024 |